The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection
- PMID: 2301035
- DOI: 10.1097/00007890-199001000-00019
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection
Abstract
In renal transplantation, preformed cytotoxic antibody against donor HLA class I antigens causes hyperacute rejection of renal allografts, but its pathogenic significance when it develops in the posttransplant period is unknown. In the present studies we describe the clinical and pathologic features of patients with rejection associated with anti-class I. In the course of 400 consecutive cadaveric renal transplants, 7 patients were identified who had antibody against donor class I HLA antigens in association with atypical but distinctive patterns of rejection. All 7 were presensitized. In 3 patients, the transplant had been inadvertently performed with a positive donor-specific T cell crossmatch. In the remaining 4, the T cell crossmatch on current sera was negative but became positive posttransplant. The clinical picture was deterioration of graft function with rapid onset of oliguria, apparently due to acute tubular necrosis, but with persistence of blood flow demonstrable by radioisotope scan studies. Renal histology showed that the typical lesions observed in cell-mediated rejection, such as tubulitis and interstitial infiltration, were absent. Granular complement deposition (6), polymorphonuclear infiltration (6), and endothelial injury in the microvasculature (6) were common, and mononuclear infiltrates were absent (2) or not prominent (4). In 3 patients the glomerular changes resembled a picture of hemolytic uremic syndrome, with capillary fibrin thrombi and widening of the subendothelial space. IgG staining was negative. The pathologic features suggest that anti-class I antibody appearing or persisting in the early posttransplant period injures the endothelium of the microvasculature, with the clinical presentation different from that of hyperacute rejection. Particularly in sensitized patients, rapid deterioration in function, leading to a picture of acute tubular necrosis, with pathologic features of endothelial injury in the microcirculation, should suggest the diagnosis of anti-class I-mediated rejection.
Similar articles
-
The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.Transplantation. 1992 Mar;53(3):550-5. Transplantation. 1992. PMID: 1549846
-
Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.Transplantation. 1996 Jun 15;61(11):1586-92. doi: 10.1097/00007890-199606150-00007. Transplantation. 1996. PMID: 8669102
-
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.Kidney Int. 2017 Mar;91(3):729-737. doi: 10.1016/j.kint.2016.10.040. Epub 2017 Jan 16. Kidney Int. 2017. PMID: 28104301
-
Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.Nephrology (Carlton). 2016 Jul;21 Suppl 1:4-8. doi: 10.1111/nep.12777. Nephrology (Carlton). 2016. PMID: 26971899 Review.
-
[Significance of histocompatibility tests].Rinsho Byori. 1990 Feb;38(2):151-6. Rinsho Byori. 1990. PMID: 2139476 Review. Japanese.
Cited by
-
Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable?Adv Biomed Res. 2012;1:40. doi: 10.4103/2277-9175.100139. Epub 2012 Aug 28. Adv Biomed Res. 2012. PMID: 23326771 Free PMC article.
-
Timing of intraoperative crystalloid infusion may decrease total volume of infusate without affecting early graft function in live related renal transplant surgery: A randomized, surgeon-blinded clinical study.Indian J Urol. 2022 Jan-Mar;38(1):53-61. doi: 10.4103/iju.iju_239_21. Epub 2022 Jan 1. Indian J Urol. 2022. PMID: 35136296 Free PMC article.
-
The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase.Kidney Int Rep. 2022 May 5;7(7):1653-1664. doi: 10.1016/j.ekir.2022.04.097. eCollection 2022 Jul. Kidney Int Rep. 2022. PMID: 35812292 Free PMC article.
-
Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.J Am Soc Nephrol. 2015 Jul;26(7):1711-20. doi: 10.1681/ASN.2014060588. Epub 2014 Nov 6. J Am Soc Nephrol. 2015. PMID: 25377077 Free PMC article.
-
The diagnostic value of transcription factors T-bet/GATA3 ratio in predicting antibody-mediated rejection.Clin Dev Immunol. 2013;2013:460316. doi: 10.1155/2013/460316. Epub 2013 Oct 23. Clin Dev Immunol. 2013. PMID: 24235972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials